Source: Abstracts. Conference titles: Meeting of the Brazilian Society for Immunology. Unidades: ICB, FCFRP
Assunto: IMUNOLOGIA
ABNT
PEREIRA, W O et al. Down regulation of Hematopoietic SH2 domain containing (HSH2D) in the progression of the chronic myelogenous leukemia. 2006, Anais.. São Paulo: Instituto de Ciências Biomédicas, Universidade de São Paulo, 2006. . Acesso em: 21 out. 2024.APA
Pereira, W. O., Carvalho, D. D., Leroy, J. M. G., Bueno-da-Silva, A. E., Jacysyn, J. F., Tobo, P. R., et al. (2006). Down regulation of Hematopoietic SH2 domain containing (HSH2D) in the progression of the chronic myelogenous leukemia. In Abstracts. São Paulo: Instituto de Ciências Biomédicas, Universidade de São Paulo.NLM
Pereira WO, Carvalho DD, Leroy JMG, Bueno-da-Silva AE, Jacysyn JF, Tobo PR, Zanichelli MA, Camanho D, Collassanti MD, Lopes LR, Hamerschlak N, Okamoto OK, Moreira-Filho CA, Castro FA de, Amarante-Mendes JGP. Down regulation of Hematopoietic SH2 domain containing (HSH2D) in the progression of the chronic myelogenous leukemia. Abstracts. 2006 ;[citado 2024 out. 21 ]Vancouver
Pereira WO, Carvalho DD, Leroy JMG, Bueno-da-Silva AE, Jacysyn JF, Tobo PR, Zanichelli MA, Camanho D, Collassanti MD, Lopes LR, Hamerschlak N, Okamoto OK, Moreira-Filho CA, Castro FA de, Amarante-Mendes JGP. Down regulation of Hematopoietic SH2 domain containing (HSH2D) in the progression of the chronic myelogenous leukemia. Abstracts. 2006 ;[citado 2024 out. 21 ]